The Vallabh/Minikel lab at the Broad Institute has received FDA clearance for an investigational siRNA therapeutic designed to reduce prion protein expression in patients with prion disease.
A new meta-analysis indicates that low-intensity shockwave therapy (LiSWT) and platelet-rich plasma (PRP) injections, alone or combined, significantly improve erectile function compared to control therapies.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.